IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 355 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2024. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,216,892 | +97.8% | 24,054 | +77.3% | 0.01% | +75.0% |
| Q3 2023 | $615,354 | +3350.5% | 13,566 | +2618.6% | 0.00% | – |
| Q1 2023 | $17,834 | -99.8% | 499 | -99.7% | 0.00% | -100.0% |
| Q4 2022 | $7,189,633 | +14.0% | 190,353 | +33.6% | 0.04% | +21.9% |
| Q3 2022 | $6,304,000 | +16.1% | 142,522 | -2.8% | 0.03% | +28.0% |
| Q2 2022 | $5,429,000 | +49254.5% | 146,656 | +77087.4% | 0.02% | – |
| Q3 2019 | $11,000 | -60.7% | 190 | -55.8% | 0.00% | – |
| Q2 2019 | $28,000 | +40.0% | 430 | +78.4% | 0.00% | – |
| Q1 2019 | $20,000 | -88.6% | 241 | -94.0% | 0.00% | -100.0% |
| Q1 2018 | $176,000 | -38.7% | 4,000 | -33.3% | 0.00% | -50.0% |
| Q4 2016 | $287,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sicart Associates LLC | 367,360 | $14,768,000 | 10.67% |
| BB BIOTECH AG | 7,461,295 | $299,944,000 | 9.81% |
| TANAKA CAPITAL MANAGEMENT INC | 83,399 | $3,353,000 | 7.39% |
| DOWLING & YAHNKE LLC | 675,843 | $27,169,000 | 2.89% |
| Opus Point Partners Management, LLC | 78,900 | $3,172,000 | 2.35% |
| Motley Fool Asset Management LLC | 259,000 | $10,412,000 | 2.25% |
| ARK Investment Management | 127,563 | $5,128,000 | 1.48% |
| Motley Fool Wealth Management, LLC | 325,965 | $13,104,000 | 1.26% |
| PINNACLE ASSOCIATES LTD | 1,514,710 | $60,891,000 | 1.16% |
| Bellevue Group AG | 205,253 | $8,251,000 | 1.10% |